Lonza Confident Of 2020 Target For Moderna COVID-19 Vaccine Supply

Lonza is confident that U.S. and Swiss plants it is building to help make Moderna's COVID19 vaccine candidate will be ready for commercial production this year, executives at the Swiss company said on Tuesday.

Disclaimer : Mytimesnow (MTN) lets you explore worldwide viral news just by analyzing social media trends. Tap read more at source for full news. The inclusion of any links does not necessarily imply any endorsement of the views expressed within them.